This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Suzhou Pharmavan Cancer Research Center Co., Ltd., Suzhou Pharmavan Co., Ltd.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Jiangsu, CN (2019)
- Suzhou, CN (2022)
Company Filing History:
1 out of 1 
1 out of 3 Years Active: 2019-2022
Title: The Innovative Contributions of Haimei Feng in Cancer Research
Introduction: Haimei Feng, an accomplished inventor based in Jiangsu, China, has made significant strides in the field of pharmaceutical development, focusing on innovative solutions for the treatment of autoimmune diseases and tumors. With her inventive spirit, she has been instrumental in advancing medical science, specifically in combating difficult-to-treat conditions such as systemic lupus erythematosus, psoriasis, and triple-negative breast cancer.
Latest Patents: Haimei Feng holds a notable patent titled "Glaucocalyxin A derivative and preparation method and application thereof." This patent outlines a specific glaucocalyxin A derivative and includes a comprehensive method for its preparation. The derivative holds promise as a pharmaceutical agent aimed at treating various autoimmune diseases and tumors, marking a crucial step in enhancing treatment options.
Career Highlights: Throughout her career, Haimei Feng has built a reputation as a leading innovator in the pharmaceutical industry. Her work at Suzhou Pharmavan Cancer Research Center Co., Ltd. showcases her dedication to cancer research and the development of targeted therapies. Feng's commitment to innovative research has not only advanced her personal career but has also contributed significantly to the overall advancement of medical science.
Collaborations: Haimei Feng has collaborated with talented colleagues including Rensen Zhou and Xiang Chen. These partnerships have fostered an environment of creativity and innovation, enabling them to work together on groundbreaking research aimed at combating severe medical conditions.
Conclusion: The contributions of Haimei Feng to the field of biotechnology and pharmacology exemplify the impact of innovative inventions in medicine. As she continues to develop her work and influence in cancer research, her patents will serve as a foundation for future advancements that can significantly improve the lives of patients suffering from challenging diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile